Design of an innovative system for the detoxification of pharmaceutical wastewater from pharmaceutical facilities.
Published:
Nov 30, 2023
Keywords:
APIs, wastewater, pharmaceutical industries
Abstract
The concentration of Active Pharmaceutical Ingredients (APIs) in wastewater is directly affected by the increasing worldwide use of pharmaceuticals. The release of the wastewater may contaminate the surface water and marine life. Conventional wastewater treatment plants are unable to remove completely all APIs. The most frequently used methods are conventional activated sludge system (CAS) and membrane biological reactors (MBR), based on studies the removal percentage of APIs was lower than 10% in some compounds. Catalytic hydrogenation is a highly effective water treatment process that offers superior selectivity and reactivity compared to traditional methods, without the use of any chemicals. There is no need for additional wastewater treatment to remove any toxic byproducts that may be produced, making the process cost-effective and efficient. The catalytic reactions of hydrogenation are also rapid reactions with short residence times and smaller reactors, reducing both the operations and installation costs. The pilot will operate under room temperature and pressure conditions. This pilot will fully operate with renewable energy-solar energy (RES). The main components of the developed pilot system are a mixing tank, a filtration system, a water electrolysis unit operating with RES and a catalytic reactor where the concentrated stream from filtration system will be treated. In this reactor, the pharmaceutical compounds in the presence of a catalyst will be hydrogenated and converted to non-critical organic matter.
Article Details
- How to Cite
-
Giouni, E. A., kyriazi, M., Malamis, D., & LOIZIDOU, M. (2023). Design of an innovative system for the detoxification of pharmaceutical wastewater from pharmaceutical facilities. Technical Annals, 1(4). https://doi.org/10.12681/ta.35979
- Section
- Environment
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Downloads
Download data is not yet available.
References
P. Verlicchi, M. Al Aukidy, E. Zambello, Occurrence of pharmaceutical compounds in urban wastewater: Removal, mass load and environmental risk after a secondary treatment—A review, Sci. Total Environ. 429 (2012) 123–155.
Michael, L. Rizzo, C.S. McArdell, C.M. Manaia, C. Merlin, T. Schwartz, C. Dagor, D. Fatta-Kassinos, Urban wastewater treatment plants as hotspots for the release of antibiotics in the environment: A review, Water Res. 47 (2013) 957–995.
F. Sacher, F.T. Lange, H.-J. Braunch, I. Blankerhorn, Pharmaceuticals in groundwaters: Analytical methods and results of a monitoring program in Baden- Wurttemberg, Germany, J. Chromatorg. A 938 (2001), 199–210.
S.D. Constanzo, J. Murby, J. Bates, Ecosystem response to antibiotics entering the aquatic environment. Mar. Pollut. Bull. 51 (2005) 218–223.
A.J. Watkinson, E.J. Murby, D.W. Kolpin, S.D. Costanzo, The occurrence of antibiotics in an urban watershed: From wastewater to drinking water, Sci. Total Environ. 407 (2009) 2711–2723.
C. McArdell, E. Molnar, M.J.F. Suter, W. Giger, Occurrence and fate of macrolide antibiotics in wastewater treatment plants and in the Glatt Valley watershed, Switzerland, Environ. Sci. Technol. 37 (2003) 5479–5486.
K.C. Makris, S.A. Snyder, Screening of pharmaceuticals and endocrine disrupting compounds in water supplies of Cyprus, Water Sci. Technol. 62(11) (2010), 2720–2728.
M.D. Hernando, E. Heath, M. Petrovic, D. Barcelo, Trace-level determination of pharmaceutical residues by LC-MS/MS in natural and treated waters. A pilot survey study, Anal. Bioanal. Chem. 385 (2006) 985–991.
P.E. Stackelberg, E.T. Furlong, M.T. Meyer, S.D. Zaugg, A.K. Henderson, D.B. Reissman, Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking-water treatment plant, Sci. Total Environ. 329 (2004) 99–113.
4J. Radjenović, M. Petrović, D. Barceló, and M. Petrović, Advanced mass spectrometric methods applied to the study of fate and removal of pharmaceuticals in wastewater treatment, TrAC – Trends Anal. Chem., 2007.
Li, B. and Zhang, T., Mass flows and removal of antibiotics in two municipal wastewater treatment plants, 2011, Chemosphere, vol. 83, issue 9, 1284-1289.
Yang, Y., Ok, Y.S., Kim, K.-H., Kwon, E.E., Tsang, Y.F., Occurrences and removal of pharmaceuticals and personal care products (PPCPs) in drinking water and water/sewage treatment plants: A review, 2017, Sc. Total Environ., Vol. 596-597, 303-320.
Tim aus der Beek, Frank-Andreas Weber, Axel Bergmann, Pharmaceuticals in the environment: Global occurrence and potential cooperative action under the Strategic Approach to International Chemicals Management (SAICM), Umweltbundesamt Texte 67/2016.
Emmanuel Sunday Okeke, Timothy Prince Chidike Ezeorba, Charles Obinwanne Okoye, Yao Chen, Guanghua Mao, Weiwei Feng , Xiangyang Wu, Environmental and health impact of unrecovered API from pharmaceutical manufacturing wastes: A review of contemporary treatment, recycling and management strategies, Sustainable Chemistry and Pharmacy Volume 30, December 2022.
Brooks, B.W, 2014, Fish on Prozac (and Zoloft): ten years later, Aqua. Toxicol 1151, 61-67.
Gretchen M. Bruce, Richard C. Pleus, and Shane A. Snyder, Toxicological Relevance of Pharmaceuticals in Drinking Water, Environ. Sci. Technol. 2010, 44, 14, 5619–5626.
Niina M Vieno, Heli Härkki, Tuula Tuhkanen, Leif Kronberg, Occurrence of pharmaceuticals in river water and their elimination in a pilot-scale drinking water treatment plant, Environ Sci Technol. 2007 Jul 15;41(14):5077-84.
WHO Library Cataloguing-in-Publication Data, Pharmaceuticals in drinking-water, 2012 Gomez Cortes, L., Marinov, D., Sanseverino, I., Navarro Cuenca, A., Niegowska, M.
Barbara Kasprzyk-Hordern, Richard M Dinsdale, Alan J Guwy, The removal of pharmaceuticals, personal care products, endocrine disruptors, and illicit drugs during wastewater treatment and its impact on the quality of receiving waters, Water Res. 2009 Feb;43(2):363-80.
V Gabet-Giraud, C Miège, J M Choubert, S Martin Ruel, M Coquery, Occurrence and removal of estrogens and beta blockers by various processes in wastewater treatment plants, Sci Total Environ. 2010 Sep 1;408(19):4257-69.
Maria Klavarioti , Dionissios Mantzavinos, Despo Kassinos, 2009, Environ Int. 2009 Feb;35(2):402-17.
Ternes, T.A. (1998) Occurrence of Drugs in German Sewage Treatment Plants and Rivers. Water Research, 32, 3245 3260.
David Bendz, Nicklas A Paxéus, Timothy R Ginn, Frank J Loge, Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden, J Hazard Mater. 2005 Jul 15;122(3):195-204.
V. Emzhina, E. Kuzin, E. Babusenko, N. Krutchinina, Photodegradation of tetracycline in presence of H2O2 and metal oxide based catalysts, Journal of Water Process Engineering Volume 39, February 2021.
Yingtao Sun, Ruixin Yi, Chun Hu, and Lai Lyu, Enhanced purification efficiency for pharmaceutical wastewater through a pollutant-mediated H2O2 activation pathway over CuZnS nano-aggregated particles, Environ. Sci.: Nano, 2022, 9, 4317 4324.
Junhua Li, Hong He, Chun Hu, Jincai Zhao, The abatement of major pollutants in air and water by environmental catalysis, Front Environ Sci Eng. 2013;7(3):302-325.
Nantia A. Pantelidou, Christodoulos P. Theologides, Georgios G. Olympiou, Petros G., Savva, Marlen I. Vasquez & Costas N. Costa, Catalytic removal of pharmaceutical compounds in water medium under an H2 stream over various metal-supported catalysts: A promising process, Desalination and Water Treatment, 1-8, 2014.
Meghdad Pirsaheb, Hiwa Hossaini, Hosna Janjani, Reclamation of hospital secondary treatment effluent by sulfate radicals based–advanced oxidation processes (SR-AOPs) for removal of antibiotics, Microchemical Journal Volume 153, March 2020.
Divya Dixit, Pooja Thanekar , Vinay M. Bhandari, Degradation of API pollutants using hydrodynamic cavitation and process intensification, Chemical Engineering and Processing - Process Intensification Volume.172, February 2022.
Costas N. Costa, Petros G. Savva, Jose´ Luis G. Fierro, Angelos M. Efstathiou, Industrial H2-SCR of NO on a novel Pt/MgO–CeO2 catalyst, Applied Catalysis B: Environmental 75 (2007) 147–156.
Costas L. Constantinou, Costas N. Costa, and Angelos M. Efstathiou, The Remarkable Effect of Oxygen on the N2 Selectivity of Water Catalytic Denitrification by Hydrogen, Environ. Sci. Technol. 2007, 41, 3, 950–956.
P. G. Savva, C. N. Costa & A. M. Efstathiou, The mechanism of reduction of NO with H2 in strongly oxidizing conditions (H2-SCR) on a novel Pt/MgO-CeO2 catalyst: Effects of reaction temperature, Kinetics and Catalysis September 2008.
Y Guo, P S Qi, Y Z Liu, A Review on Advanced Treatment of Pharmaceutical Wastewater, et al 2017 IOP Conf. Ser.: Earth Environ. Sci. 63 012025.
Porcel Rodriguez, E., Stefanelli, F., and Lettieri, T., Selection of substances for the 4th Watch List under the Water Framework Directive, JRC Technical Report, 2022.
